The European Commission, the Heads of Medicines Agency (HMA) and the European Medicines Agency have issued recommendations for action to avoid shortages of key antibiotics used to treat respiratory tract infections among patients in Europe during the next winter season. The recommendations, developed by the Medical Shortages and Safety Steering Group (MSSG), complete the process of developing an EU list of critical medicines. In close cooperation with EU member states, the European Commission will undertake operational follow-up, including possible joint procurement if necessary.
The president of URPLiPB has published information on recommendations issued by the EC, HMA and EMA on measures to avoid shortages of key antibiotics for treating respiratory tract infections during the upcoming winter season.
If demand in the upcoming winter season is similar to the average level of consumption in previous years, the data collected suggests that the EU supply of oral formulations covering key first- and second-line antibiotics for the treatment of respiratory tract infections will match demand in the upcoming winter season. The EMA and the European Health Emergency Preparedness and Response Authority (HERA) will continue to work with responsible part...
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in